The core activity of Clemedi is the development and marketing of diagnostic tests for infectious diseases, particularly tuberculosis, by combining DNA sequencing and artificial intelligence (Machine Learning). These tests enable doctors to prescribe targeted antibiotic treatment by determining the resistance of bacteria to various antibiotics.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Diagnostic solution for identifying mycobacteria and for predicting antibiotic susceptibility; includes the Tuberculosis test Tuberculini for detecting drug-resistant tuberculosis directly from sputum.
Molecular diagnostic reagents
Reagents for laboratory use for the molecular diagnosis of infectious diseases, used in DNA sequencing and the analysis of resistance markers.
Diagnostic software for laboratories
Software for laboratory use to analyze sequencing data, generate reports and predict antibiotic susceptibility based on resistance markers.
Knowledge
No knowledge articles yet
Once Clemedi AG has claimed this profile, we'll publish editorial articles and case studies here together.